|
![]() |
|||
|
||||
OverviewMicrobiome in Cancer and Autoimmunity - Part A, Volume 394 offers a comprehensive exploration of the intricate relationship between the human microbiome and the development of cancer and autoimmune diseases. Delving into cutting-edge research and clinical insights, this groundbreaking work elucidates the role of microbial communities in influencing immune responses, disease pathways, and therapeutic outcomes. From deciphering the molecular mechanisms underlying microbiome-host interactions to unraveling the impact of dysbiosis on disease progression, the book provides a multifaceted analysis of the microbiome's pivotal role in cancer and autoimmunity. With contributions from leading experts in the field, this book serves as a pivotal resource for researchers, clinicians, and healthcare professionals seeking to understand and harness the therapeutic potential of the microbiome in combating cancer and autoimmune conditions. Full Product DetailsAuthor: Manisha Singh (Department of Lymphoma/ Myeloma, The University of Texas, MD Anderson Houston, Houston, Texes, USA)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Weight: 0.450kg ISBN: 9780443317064ISBN 10: 0443317062 Pages: 226 Publication Date: 01 July 2025 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents1. Introduction to Microbiomes in Health and Disease Santosh Kumar, Prachi Agrawal, Prachi Mendhey, Robins Kumar, Abhishek Dadsena, Prakash Kaushik and Subham Patel 2. Microbiome Dysbiosis in Cancer Roza Nurieva 3. Role of Microbiomes in Cancer Progression Sadhna Aggarwal 4. Microbiome-Mediated Immune Modulation in Tumor Microenvironment Abishai Dominic 5. Microbiome and Cancer Immunotherapy Shweta Dubey and Mohini Vig 6. The Multipotential Effect of Microbiome in Lung Cancer Development and Progression Seyed Javad Moghaddam, Nastaran Karimi, Angélica Baca De Anda, Emre Aksan, Maria T. Grimaldo and Rachel Yang 7. Role of microbiome in anti-CAR-T cell therapy Salah-Eddine Bentebibel and Reham Abdel-WahabReviewsAuthor InformationManisha Singh, PhD, is a trained human and mouse immunologist and during the last 10 years, she has specialized in cancer immunology. The main focus of her work has been to increase the efficacy and understand the molecular mechanisms of various cancer immunotherapies. She is serving as the principal investigator on a 2-year grant ($545,486), having been funded by the US Department of Defense. Dr. Singh's current research is focused on understanding the role of inflammation in immune suppression and resistance to immunotherapy in cancer. Recently, she has submitted the NIH-R01 grant in which she proposed to study the role of IL-1α in immunotherapy induced resistance. She has published 24 peer-reviewed articles and many abstracts in prestigious journals such as Nature Communication, Journal of Immunology, and Journal of Clinical Investigator. Her work has been cited by several prestigious, peer-reviewed, international journals. Tab Content 6Author Website:Countries AvailableAll regions |